Literature DB >> 9394269

Acute phase proteins in major depression.

M Berk1, A A Wadee, R H Kuschke, A O'Neill-Kerr.   

Abstract

Extensive evidence exists associating depression with changes in the immune system. The present study evaluates the levels of complement components C3 and C4, C-reactive proteins, and IL-6 in patients who met DSM-III-R diagnostic criteria for major depressive disorder, as well as controls. Whereas no significant differences between the mean levels of C3 could be detected between depressed patients and controls, the levels of C4, IL-6 (where detected), and C-reactive protein were significantly raised in the group with a depressive disorder. Our study suggests an interaction between psychological state and immune systems operative in host defenses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9394269     DOI: 10.1016/s0022-3999(97)00139-6

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  51 in total

Review 1.  Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Authors:  Michael Maes
Journal:  Metab Brain Dis       Date:  2012-07-07       Impact factor: 3.584

Review 2.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 3.  Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Authors:  George Anderson; Michael Berk; Olivia Dean; Steven Moylan; Michael Maes
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

4.  What can post-mortem studies tell us about the pathoetiology of suicide?

Authors:  Ghanshyam N Pandey; Yogesh Dwivedi
Journal:  Future Neurol       Date:  2010-09

5.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

6.  Association between inflammatory cytokines and the risk of post-stroke depression, and the effect of depression on outcomes of patients with ischemic stroke in a 2-year prospective study.

Authors:  Jian-Tong Jiao; Chao Cheng; Ying-Jun Ma; Jin Huang; Min-Chao Dai; Chen Jiang; Cheng Wang; Jun-Fei Shao
Journal:  Exp Ther Med       Date:  2016-06-30       Impact factor: 2.447

7.  Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood.

Authors:  Najib Aziz; John L Fahey; Roger Detels; Anthony W Butch
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 8.  Sarcopenia and the Common Mental Disorders: a Potential Regulatory Role of Skeletal Muscle on Brain Function?

Authors:  Julie A Pasco; Lana J Williams; Felice N Jacka; Nicole Stupka; Sharon L Brennan-Olsen; Kara L Holloway; Michael Berk
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

9.  Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study.

Authors:  G Cizza; F Eskandari; M Coyle; P Krishnamurthy; E C Wright; S Mistry; G Csako
Journal:  Horm Metab Res       Date:  2009-04-30       Impact factor: 2.936

Review 10.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.